Flow chemistry engineering specialists Vapourtec have strengthened their presence across Europe with the signing of a distribution deal with Belgium-based Analis. Analis Sales and Marketing Manager Ken De Roover commented: “We are delighted to strengthen our chemical synthesis portfolio with Vapourtec and will be distributing their full range of flow...
Founder and Chairman, Dr David Taylor, of Guildford based MR Solutions has been shortlisted as an Innovation Entrepreneur of the Year for London and the South East in the 2018 NatWest Great British Entrepreneur Awards. The awards have had a record number of entries with businesses from across the south east vying for a place on the shortlist...
Telstar has delivered a total of six highcontainment multi-chamber, multi-functionalisolators to the Finnish pharmaceutical Orion. Pharmaceutical company Orion entrusted Telstar as a specialized partner in containment technology to supply various isolators to sites in Finland during the last five years. All of the containment isolators were designed and manufactured by Telstar in the United Kingdom.....
DefiniGEN, the world leader in human iPSC differentiation and disease modelling, announces the appointment of Professor Sir John Savill as a Non-Executive Director of the Board. Sir John will bring his expertise in translational science to DefiniGEN enabling the company to accelerate the development of new products and services which can improve the efficiency and economics of drug development....
Lunaphore Technologies SA, a Swiss Company developing innovative next-generation devices for cancer tissue diagnostics, and A. Menarini Diagnostics S.r.l., one of Europe’s leading diagnostic solution providers and part of the Menarini Group, jointly announce the start of a strategic partnership bringing to the market a new and innovative system, using Lunaphore’s technology....
Evotec AG has announced a strategic alliance with Novo Nordisk to discover and develop novel small molecule therapies to treat patients suffering from diabetes and obesity as well as co-morbidities such as nonalcoholic steatohepatitis ("NASH"), cardiovascular diseases, and diabetic kidney disease. Evotec will apply its drug discovery platform, especially in ligand-based design...
Optibrium™, a developer of software for drug discovery, has announced it had signed a collaboration agreement with Intellegens, a company developing novel artificial intelligence (AI) software. The collaboration will provide Optibrium clients with access to advanced, proprietary deep learning methods that will extend and improve predictive models to guide the more efficient design and selection of high quality drug candidates.
Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced that CENTOGENE AG, the worldwide leader in elucidating rare disease genetics for patients, clinicians and pharmaceutical partners, and Evotec entered into a global strategic collaboration agreement for joint drug discovery projects, developing compounds to treat rare genetic diseases. Evotec and CENTOGENE initiated the collaboration to develop a...
Inoviem Scientific, a Contract Research Biotech (CRB), announces a service-based partnership with XoNovo, a preclinical-stage biopharmaceutical company developing a proprietary small molecule for the treatment of neurodegenerative diseases. Financial terms of the partnership were not disclosed. The partnership aims to generate crucial information concerning...
Schauenburg Analytics, parent company of Markes International and SepSolve Analytical, is set to officially open new state-of-the-art laboratories and training facilities in Offenbach am Main, Germany, on 18 September 2018. Both Markes International and SepSolve Analytical are undergoing rapid expansion, with Markes manufacturing instrumentation for thermal desorption and related sampling techniques....
Evotec AG has announced that CHDI Foundation, Inc. has extended its collaboration with Evotec through to 2023. Over this period, CHDI may fund up to 75 full-time scientists at Evotec. The collaboration was initiated in 2006 and has grown considerably over this period to fully utilise Evotec's best-in-class integrated neuroscience platform....
Sartorius Stedim Biotech a leading international supplier for the biopharmaceutical industry, and Repligen Corporation a global life sciences company focused on bioprocessing technologies, have entered into a collaboration agreement to integrate Repligen’s XCell™ ATF cell retention control technology into SSB’s BIOSTAT® STR large-scale single-use bioreactors...
First Minister Nicola Sturgeon today convened industry, academic and clinical experts in Precision Medicine from across Scotland and across the globe, bringing together the sector to declare its intention to lead the world in this exciting new development. Scotland’s Precision Medicine Summit, which was held in Perth, was co-chaired by University of Glasgow....
Clinithink has been selected to receive the RARE Champion of Hope – Collaborations in Science and Technology award at the 7th Annual RARE Patient Advocacy Summit. Over 200 individuals and organizations worldwide were nominated by their peers for a RARE Champion of Hope award...
Laborama will celebrate its 20th edition in 2019 in a new location. After more than 10 years in Brussels Kart Expo, Laborama will call Palace 3 of Brussels Expo its new home. Over the years, Laborama has grown to become the largest trade fair for the laboratory sector in Belgium and Luxembourg...
BioAscent Discovery Limited has announced the appointments of Angus Morrison, PhD, as Director of Chemistry and Stuart McElroy, PhD,as Director of Biosciences, to oversee the development and delivery of BioAscent’s integrated drug discovery services....
Optical Surfaces Ltd announces that it has received an order from the UK Atomic Weapons Establishment (AWE) for twelve ultra-fast focusing 370mm diameter aspheric lenses for its Orion petawatt laser research facility. World-class expertise and cutting-edge science, engineering and technology lie at the heart of AWE work, spanning the life cycle of nuclear warheads from initial concept and design...
Promega UK the Life Sciences Company, based on the University of Southampton Science Park in Hampshire, is proud to announce that two UK iGem (The International Genetically Engineered Machine Foundation) groups are among 10 international projects to have won sponsorship from Promega Corporation as part of the worldwide iGem competition for up and coming scientists. Two teams from the University of Manchester and...
As part of this collaboration, Horizon will lead the development and application of single cell RNAseq-linked pooled CRISPR screening using a key discovery paradigm of the pharma partner. Horizon will use the development process, acquired infrastructure, and optimization data in order to further develop and improve these tools to offer to future partners, as part of its research services operations...
Sphere Fluidics, a company providing single cell analysis systems underpinned by its patented picodroplet technology, has announced that Tris Vaughan, PhD FRSB has joined its scientific advisory board (SAB). Dr Vaughan’s appointment will further strengthen the company’s understanding of biopharmaceutical discovery and cell line development and help translate its technology to an industrial context...
Professor Gerry McCann has been awarded a prestigious research professorship from the National Institute for Health Research (NIHR). A cardiology consultant from Leicester has been awarded a prestigious research professorship from the National Institute for Health Research (NIHR). Professor Gerry McCann, cardiology consultant at Leicester’s Hospitals and professor of cardiac imaging....
Peter Huber Kältemaschinenbau AG continues its international expansion. In early August, Huber opened a new sales office based in Guangzhou, China. The new subsidiary will serve end users and dealers in China under the name "Huber China". On Wednesday, August 1, 2018, the opening ceremony of the new corporate building in Guangzhou took place. Numerous business partners and customers accepted the invitation and...